Page 48 - FINAL PROGRAMME 2017
P. 48

OVERVIEW MONDAY, 3 JULY 2017
08:30 - 09:30
09:30 - 10:00 10:00 - 11:30 10:00 - 11:30 10:00 - 11:30
10:00 - 11:30 10:00 - 11:30 10:00 - 11:30 11:45 - 12:45
11:45 - 12:45
11:45 - 12:15
11:45 - 12:45
13:00 - 14:00
SESSION 01: KEYNOTE SESSION
• Human Reproduction keynote lecture - Autologous cell therapy with CD133+ bone marrow-derived stem cells for refractory Asherman’s syndrome and endometrial atrophy: a pilot cohort study
- Carlos Simon Valles, Spain
• Non-invasive prenatal testing (NIPT) - state of the art
- Dennis Lo, Hong Kong
COFFEE BREAK (IN THE EXHIBIT HALL)
Plenary 1
Hall 2 Plenary 1 Plenary 2
Room A Room B Room W+X Room C Plenary 2
Room A
Room B
Room W+X
Hall 2
SESSION 02: SESSION 03:
SESSION 04: INFERTILITY
SESSION 05:
SESSION 06:
SESSION 07:
SESSION 08:
NOVEL IDEAS IN EMBRYOLOGY
REFINING PROTOCOLS
THE ROLE OF GENES TESTIS STRUCTURE IN MALE
IMPROVING IMPLANTATION
DEVELOPMENTS IN GENETIC TESTING
LONG-TERM CONSEQUENCES IN ART
OVARIAN REJUVENATION: FOR REAL OR JUST A DREAM?
• Mitochondrial transfer- can it improve oocyte quality?
- Jacques Cohen, U.S.A.
• Improving ovarian response through ovarian tissue activation
- Kazuhiro Kawamura, Japan
SESSION 09: DATA REPORTING SESSION
• Data from the ESHRE PGD Consortium
- Martine De Rycke, Belgium
• First results of the ESHRE study into the evaluation of oocyt euploidy by microarray analysis (ESTEEM), a randomized controlled trial to test preimplantation genetic testing for aneuploidy
- Karen Sermon, Belgium
SESSION 10: FERTILITY SOCIETY OF AUSTRALIA EXCHANGE LECTURE
• New strategies for ovarian preservation during cancer treatment: Elimination of PUMA confers protection against chemotherapy- mediated oocyte loss - Quynh-nhu Nguyen, Australia
SESSION 11: PARAMEDICAL INVITED SESSION: SPERM MESSAGING - WHAT’S THE STORY?
• Genetic screening in cases of extreme poor spermatogenesis
- Liliana Ramos, The Netherlands
• Evaluating oocyte activation potential of sperm using calcium pattern analysis
- Bjorn Heindryckx, Belgium
LUNCH BREAK (IN THE EXHIBIT HALL)
48


































































































   46   47   48   49   50